Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Cachexia
| Cachexia | |
|---|---|
| Other names | Wasting syndrome |
.jpg) | |
| Person with cancer-associated cachexia | |
| Specialty | Oncology, Internal Medicine, Physical Medicine and Rehabilitation |
| Symptoms | sudden weight loss, altered eating signals |
| Prognosis | very poor |
| Frequency | 1% |
| Deaths | 1.5 to 2 million people a year |
Cachexia (/kəˈkɛksiə/[1]) is a syndrome that happens when people have certain illnesses, causing muscle loss that cannot be fully reversed with improved nutrition.[2] It is most common in diseases like cancer, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and AIDS.[3][4] These conditions change how the body handles inflammation, metabolism, and brain signaling, leading to muscle loss and other harmful changes to body composition over time.[5] Unlike weight loss from not eating enough, cachexia mainly effects muscle and can happen with or without fat loss.[6] Diagnosis of cachexia is difficult because there are no clear guidelines, and its occurrence varies from one affected person to the next.[7]
Like malnutrition, cachexia can lead to worse health outcomes and lower quality of life.[8][9][10]
- ^ "Cachexia | Definition of Cachexia by Lexico". Lexico Dictionaries | English. Archived from the original on 8 November 2019.
- ^ Cite error: The named reference
fearon-2011was invoked but never defined (see the help page). - ^ Cederholm T, Barazzoni R, Austin P, et al. (2017). "ESPEN guidelines on definitions and terminology of clinical nutrition". Clinical Nutrition. 36 (1): 49–64. doi:10.1016/j.clnu.2016.09.004. hdl:11368/2883964. PMID 27642056.
- ^ Muscaritoli M, Anker S, Argilés J, et al. (2009). "Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"". Clinical Nutrition. 29 (2): 154–159. doi:10.1016/j.clnu.2009.12.004. PMID 20060626.
- ^ Ferrer M, Anthony TG, Ayres JS, et al. (2023). "Cachexia: A systemic consequence of progressive, unresolved disease". Cell. 186 (9): 1824–1845. doi:10.1016/j.cell.2023.03.028. PMC 11059056. PMID 37116469.
- ^ Fearon KC, Glass DJ, Guttridge DC (August 2012). "Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways". Cell Metabolism. 16 (2): 153–166. doi:10.1016/j.cmet.2012.06.011. PMID 22795476.
- ^ Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. (1 July 2018). "Cancer cachexia: Diagnosis, assessment, and treatment". Critical Reviews in Oncology/Hematology. 127: 91–104. doi:10.1016/j.critrevonc.2018.05.006. ISSN 1040-8428.
- ^ Norman K, Pichard C, Lochs H, et al. (2008). "Prognostic impact of disease-related malnutrition". Clinical Nutrition. 27 (1): 5–15. doi:10.1016/j.clnu.2007.10.007. PMID 18061312.
- ^ Evans WJ, Morley JE, Argilés J, et al. (December 2008). "Cachexia: a new definition". Clinical Nutrition. 27 (6): 793–9. doi:10.1016/j.clnu.2008.06.013. PMID 18718696. S2CID 206821612.
{{cite journal}}: CS1 maint: overridden setting (link) - ^ Bossi P, Delrio P, Mascheroni A, et al. (9 June 2021). "The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review". Nutrients. 13 (6): 1980. doi:10.3390/nu13061980. ISSN 2072-6643. PMC 8226689. PMID 34207529.
Previous Page Next Page
